NCT00030953View on ClinicalTrials.gov

Magnetic Resonance Spectroscopy to Evaluate Tourette s Syndrome

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

February 11, 2002

Study Completion Date

February 3, 2015

Conditions
Tourette Syndrome
Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

NCT00030953 - Magnetic Resonance Spectroscopy to Evaluate Tourette s Syndrome | Biotech Hunter | Biotech Hunter